VC02, carbon dioxide production V02, oxygen consumption During TPN, a substantial part of the energy is provided by glucose. In preterm newborn infants, many unanswered questions exist regarding the metabolic responses to glucose infusion. In adults, glucose infusion results in a suppression of the endogenous glucose production (1). If the glucose infusion rate is increased in these adults, the oxidation rate also increases to a maximum (I). In preterm and term infants, glucose is often infused at higher rates than in adults and it is not known whether the glucose oxidation rate may be limited. In term infants, a glucose infusion rate exceeding the maximal glucose oxidation rate may result in lipogenesis from glucose, causing a rise in metabolic rate and in RQ (2) . In a previous study in term newborn infants receiving glucose and amino acids parenterally, glucose oxidation rates were measured with a combination of indirect calorimetry and [U-"C]glucose tracer methodology (2) . Glucose infusions of 10-15 mg/kg.min were given and glucose oxidation was calculated with the assumption that under these circumstances no glucose is endogenously produced. This assumption, however, ignores the fact that the suppression of the endogenous glucose production may be incomplete or variable. In a study using [U-"C]glucose as a tracer, it was found that endogenous production was still present during i.v. infusion of glucose at 6 mg/kg. min in both SGA and AGA term infants (3) .
Using a glucose clamp technique, other investigators found no evidence for endogenous production during a glucose infusion of 8.7 mg/kg.min in preterm AGA infants (4) . To investigate to what extent continuous glucose infusion, in addition to lipids and amino acids, influences the endogenous glucose production and glucose oxidation in preterm AGA and SGA infants after 1 wk of life, we studied these parameters by combining indirect calorimetry with [U-"C]glucose infusion and measurement of "CO2 production in expiratory air, and by also determining the endogenous glucose production by measuring the plasma dilution of [U-"C]glucose, enabling us to calculate the glucose oxidation from exogenous and endogenous sources. I the study, all infants were clinically stable and were breathing room air. Mean birth wt, gestational age, and wt at the day of study are shown in Table 1 . TPN. All infants received TPN by an indwelling peripheral vein cannula from d 2 on because of an increased risk for necrotizing enterocolitis when fed orally during the first days of life (7) . Glucose, combined with minerals and trace elements (4 mL1kg.d; Pedel, Kabi, Stockholm, Sweden) was administered from birth. Once daily, 0.5 mL/kg of soluble vitamins (Soluvit, Kabi) was given i.v. Fat was given from d 2 on using a soybean emulsion (Intralipid lo%, Kabi) mixed with fat soluble vitamins 0.1 mL/kg.d (Vitalipid, Kabi). Protein was given from d 2 on using an amino acid solution (Aminovenos lo%, Fresenius, Bad Homburg, FRG). For all the infusions, the same type of syringe pump was used (Perfusor Secura GT, Braun, Melsungen, FRG). From d 3 on, and therefore also during the studies performed at d 8, all infants received a continuous infusion of glucose, lipids, and amino acids 24 h/d at a dosage shown in Table 2 .
PATIENTS AND METHODS

TPN
Study procedure. The study protocol was approved by the Human Subject Review Committee of the University Hospital Rotterdam. Written informed consent was obtained from the parents.
At d 8, indirect calorimetry was performed over 6 to 8 h. During the indirect calorimetry, a primed constant infusion of [U-'zC]glucose was given; just before and during the infusion, expiratory air samples were collected from the closed circuit calorimeter. Before and at the end of the study, a venous blood sample was collected. Urine was collected for 72 h from the 7th to the 9th d.
Indirect calorimetry. Metabolic rate and substrate use were measured by a closed circuit indirect calorimeter. Continuous measurements were performed for 6 to 8 h, as previously described (8) . Briefly, an air mixture devoid of C 0 2 enters the incubator. In a sample of the air leaving the incubator, the COz concentration is measured; thereafter all COz is filtered out by a soda-lime filter. COz is injected again into the air flow by a mass flow injector system until the same concentration of COz is measured by the infrared meter (Unor 6N, Maihak, Hamburg, FRG). The amount of C 0 2 injected into the system equals the VCOz of the infant. Thereafter, all COz is filtered by a second soda-lime filter. The amount of oxygen consumed by the infant is equal to the amount of oxygen that has to be injected into the system to keep the oxygen tension constant, as measured by polarographic oxygen cells (type 6223771, Beckman, Fullerton, t Differences between AGA and SGA infants are significant at p <
(Wilcoxon).
$Differences between AGA and SGA infants are significant at p <
CA) in the system and in a reference vessel. To compensate for changes in air pressure, the reference vessel is connected to the flow circuit by means of a capillary. The accuracy of the measurement of VOz and VC02 are tested by burning 99.8% pure butane. Measurements in the calorimeter were only performed if the RQ when burning 99.8% butane was within 2% of the theoretical value (0.609 * 0.0 15). Urinary nitrogen concentration was determined in a pooled urine sample by combustion in an automatic nitrogen analyzer (ANA 1400, Carlo Erba, Milano, Italy) by the Dumas procedure (9) . Nonprotein V02 and nonprotein VC02 were derived from the overall VOz and VCOz by correcting the values for the protein oxidation, calculated as 6.25 times the timed urinary nitrogen excretion. Nonprotein metabolic rate and partition of the nonprotein macro nutrients were calculated from nonprotein RQ and nonprotein VO* using the tables of Lusk ( 10) . Breath gas anal.vsis. Before infusion of the label, three baseline breath samples were collected during 15 min each for determination of the natural background of I3COz. Breath C02 was collected by passing a sample of the air leaving the incubator through an all-glass spiral condensor containing 10 mL of fresh 1 M NaOH. Samples were transferred to Vacutainers and stored at -20°C until analysis. Trapping of COz was shown to be complete during 15 min at a flow of 10 mL/min and, therefore, isotopic fractionation was prevented. The body bicarbonate pool was primed with 6.9 ,umol/kg of NaH1"03 (6.9 mmol/L solution) (MSD Isotopes, Dorval, Quebec, Canada) as previously described (1 1). At the same time, a [U-'-'C]glucose solution of 3.0 mmol/L (98.9% enriched, MSD Isotopes) was given as a priming dose of 0.80 mg/kg, followed by a constant infusion of 0.45 mg/kg. h using a syringe pump (type as described above). All solutions were diluted in sterile water and tested for sterility. The delivery rate of the pump during the studies was measured by dividing the difference in weight of the syringe before and after the experiment by the duration to determine the actual quantity that was administered. Once the isotope infusion was started, 15-min C02 breath samples were collected every hour for 4 h, and every 30 min for 2 to 4 more h. Before and at the end of the experiment, a plasma sample was collected and stored at -20°C.
Respiratory COz was liberated at <10-"0rr by adding 85% phosphoric acid to the NaHCO, solution. Pure C 0 2 was collected in a small glass container in liquid nitrogen, and the water was trapped in a methanol dry ice bath. The glass container with pure COz was connected to a VG Sira 10 isotope ratio mass spectrometer (VG Isotech Ltd., Middlewich, Cheshire, UK).
Results of "C abundance of both baseline and plateau were calculated as atom percent excess against the reference tank COz standard sample.
Analysis of isotope dilution in plasma. To 50 r L of plasma, methanol was added to precipitate proteins. The supernatant was washed with 5 mL hexane to remove the FFA. The methanol was evaporated to dryness. An aldonitrile pentacetate derivative was prepared according to Tserng and Kalhan (12) ; isotope dilution was measured by means of gas chromatography/mass spectrometry using chemical ionization with ammonia as the ionization gas. Calculations. The fraction of "C glucose tracer recovered in C 0 2 was calculated as follows: 
RESULTS
The results of indirect calorimetry are shown in Table 3 . None of the differences between SGA and AGA infants were significant. The production of '3COz in expiratory air rose in the first hour in all patients and reached a plateau in all patients within 3 to 4 h. An example of a characteristic study is shown in Figure  2 .
The results of the isotopic studies are shown in Table 4 . The R, calculated from plasma dilution of [U-"C]glucose in the second plasma sample during the plateau in expiratory 13C02 was 7.97 f 1.6 1 mg/kg.min in AGA infants and 8.12 +_ 1.84 mg/kg.min in SGA infants. In comparison with the exogenous glucose intake, this indicates an endogenous glucose production of 0.42 k 1.65 and -0.04 + 1.90 mg/kg. min in AGA and SGA preterm infants, respectively, (neither rate is significantly different from 0).
The glucose oxidation rates calculated from the 13C recovery in expiratory air were 4.5 1 + 1.13 and 5.4 1 & 0.60 mg/kg. min for AGA and SGA infants, respectively, when based on the factor for '-'CO2 retention in the bicarbonate pool, calculated from the energy intake of the infant (1 1). The glucose oxidation rate from exogenous and endogenous glucose was calculated from the R, and the I3C recovery (glucose oxidation = R, x "C recovery) in mg/kg.min. The glucose oxidation rate from exogenous glucose was calculated from the nonlabeled glucose infusion and the I3C recovery (glucose oxidation = glucose infusion rate x I3C recovery) in mg/kg.min.
AGA (n
The carbohydrate oxidation rate in mg/kg. min was calculated from the nonprotein RQ and nonprotein V02 according to the tables of Lusk (1 0): Our study in preterm infants demonstrates that, as in adults, a glucose infusion causes a suppression of the endogenous glucose production. In fasting term infants, Denne and Kalhan (14) found an endogenous glucose production rate of 5 mg/kg min, whereas in our study with a glucose infusion rate of 8 mg/kg. min (and continuous infusion of fat and amino acids) no significant endogenous glucose production could be measured (Table  4) . During a glucose infusion of 5.6 mg/kg. min at postnatal d 1 to 2 in preterm AGA infants, without the simultaneous administration of amino acids or lipids, Cowett et al. (15) found an endogenous glucose production of 1-2 mg/kg. min. However, in these studies, the glucose production may have been overestimated inasmuch as the glucose production that was negative was considered to be zero (1 5).
Our findings are consistent with those in a study in preterm AGA infants in which by the use of a clamp technique no endogenous glucose production could be determined (4) . In the study of Denne and Kalhan (14) , the R, was also measured using the plasma dilution of uniformly labeled glucose, whereas an "apparent" R, was calculated from the plasma dilution of glucose with a I7C atom at the C-l position. In our study, the R, is calculated from the plasma dilution of [U-13C]glucose and reflects glucose produced from both exogenous and endogenous sources. Unfortunately, because of ethical reasons, only one plasma sample at the plateau of 13COz production could be taken. Recognizing the limitations of only one plasma sample, we still believe that this sample represents the R, for several reasons. First, the fact that TPN is given continuously over days before and during the study period results in a stability of the R, in these preterm infants under thermoneutral environment conditions. This stable condition is also reflected by the presence of normoglycemia in all plasma samples taken during these studies. Second, the fact that a stable plateau in the expired "CO2 was reached after 3-4 h supports the presence of a plateau of [U-"C]glucose in plasma. Finally, the coefficient of variation of the determinations of glucose m + 6 enrichment in plasma was only 2-6%.
The absent endogenous glucose production during TPN in our study in comparison with the maintained production found in the study by Cowett et al. (3) may also be explained by the fact that in the latter study only glucose was infused. The addition of lipids may influence glucose production significantly as demonstrated by Bougneres ( 16) . The absence of endogenous glucose production noted in our study supports the assumption that glucose oxidation can be calculated from exogenous sources only during high rates of glucose infusion, as described in previous studies (2, 17) . Suppression of endogenous glucose production may, however, be incomplete under circumstances in which less glucose is given or glucose is the sole calorie source of the parenteral nutrition.
SGA newborn infants are at risk for hypoglycemia, a situation that may be caused by an impairment of the gluconeogenic pathway in the liver of these infants, demonstrated in man and in several experimental animal studies (1 8, 19). Our study, like that by Cowett et al. (3) in term infants, demonstrates no difference in the level of suppression of the glucose production during glucose infusion between AGA and SGA preterm infants.
The glucose oxidation is calculated from the plateau in expiratory I3CO2, which is the end product of all "C-labeled glucose that is oxidized. This includes not only glucose labeled at all six carbon atoms, but also glucose labeled at less than six carbon atoms. Therefore, the glucose oxidation based on the plateau in expiratory "CO2 and the R, from [U-"C]glucose dilution in plasma might be an overestimation of the "true" oxidation. Because endogenous glucose production was absent in our study, an overestimation of the glucose oxidation is not likely.
Some factors determining the optimal glucose infusion rate during TPN have been studied in adults (20) . When, in adults, a glucose infusion was increased from 4 to 7 mg/kg.min, the glucose oxidation also increased, but a further increase to 9 mg/ kg.min was no longer followed by a significant increase in oxidation (20) . It was postulated that, under the latter conditions, the infused glucose that is not directly oxidized is convened into fat as reflected by an increase in RQ and metabolic rate. Similarly, in a previous study in predominantly term newborn infants infused with glucose at rates of 10 to 15 mglkgmin, the differences between carbohydrate oxidation determined by indirect calorimetry and glucose oxidation measured by [U-"C]glucose methodology were significant (2). In our study with a glucose infusion rate of 8 mg/kgmin, a significant difference was seen in preterm AGA infants between the carbohydrate oxidation measured by indirect calorimetry and the glucose oxidation measured by stable isotopes. In fact, in some AGA infants, a negative fat oxidation was calculated, as shown by an RQ above unity. Frayn (2 1) has shown that the negative value obtained for fat oxidation during indirect calorimetry still quantitatively represents net fat oxidation, and equals total fat oxidation minus lipogenesis from carbohydrates. In the same study, it was demonstrated that, also at an RQ less than 1, indirect calorimetry cannot distinguish between simultaneous fat oxidation and synthesis. The calculated carbohydrate oxidation may therefore be overestimated as suggested previously (2) and include carbohydrates apparently oxidized but in fact converted into fat. We therefore suggest a marked rate of lipogenesis from glucose in AGA infants that was not observed in SGA infants. Another explanation for the difference between glucose oxidation measured by tracer study and carbohydrate oxidation measured by indirect calorimetry could be intracellular glycogen oxidation. This seems to be less likely, inasmuch as both AGA and SGA GLUCOSE METABOLISM infants were studied during comparable stable conditions, and no differences between glucose and carbohydrate oxidation were found in SGA infants.
In conclusion, our study demonstrates that if glucose is parenterally infused during TPN in AGA and SGA infants at 8 mg/ kg.min, 4.7-5.3 mg/kg.min is directly oxidized (63-65%), and endogenous glucose production is absent. The glucose oxidation rate showed no significant difference from the carbohydrate oxidation rate measured by indirect calorimetry in SGA infants, but was significantly smaller than the carbohydrate oxidation rate found in AGA infants, possibly indicating increased lipogenesis from glucose in the latter group.
